Search
for
Sort by
Research 691–720 of 1000+
- Alopecia areata - risk factors, prevention possibilites and therapeutical options
- Amyopathic dermatomyositis presenting as severe alopecia and prominent eyelid edema: a case report and literature review
- Depression among Alopecia Areata Patients: Prevalence and associated factors in a Tunisian sample
- Ixekizumab Improved Refractory Erythrodermic Psoriasis with Comorbid Diffuse Alopecia: A Case Report with 52-Week Follow-Up
- To evaluate the role of interleukin-6 in alopecia areata
- Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis
- The evaluation of IL-4 VNTR intron 3 and TNF-α (rs1799964) gene polymorphisms in Egyptian patients with alopecia areata: a case–control study
- Oral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: a randomized controlled trial
- The usefulness of trichoscopy in the diagnosing of fibrosing alopecia in pattern distribution
- Tofacitinib for the treatment of alopecia areata in preadolescent children
- Association of vitamin D level with alopecia areata
- Dickkopf-1 Expression in Androgenetic Alopecia and Alopecia Areata in Male Patients
- Cardiovascular risk factors and co-morbidities in patients with Alopecia Areata: A case-control study
- Role of microneedling in treatment of alopecia areata
- Histopathologic prognostic factors for alopecia areata treated by intralesional corticosteroid
- Tofacitinib therapy for children with severe alopecia areata
- Combination tofacitinib and oral minoxidil treatment for severe alopecia areata
- Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata
- The Ratio of Typical Clubbing in Pulled-Out Hairs as a Useful Marker in Predicting the Course of Alopecia Areata
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- Trichoscopy of alopecia areata: An update
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
- Stressful lie events in alopecia areata patients: A case control study
- Patient Validation of Estimation of Health Utility Values in Alopecia Areata
- A Novel Hope for Alopecia Totalis Patients: Case Report